先天性肾上腺皮质增生症患儿的白细胞端粒长度
这项前瞻性观察性队列研究在4个儿童内分泌门诊评估了76例基因确诊的先天性肾上腺皮质增生症(CAH)患儿,两次随访间隔平均4.1±0.7个月,采用定量实时PCR测定白细胞端粒长度(LTL)。结果发现经典型CAH较非经典型、过度治疗较最佳治疗、泼尼松龙较氢化可的松治疗者的LTL更短,提示LTL或可作为监测糖皮质激素治疗的生物标志物。
要点
- 经典型CAH患儿LTL较非经典型缩短(-0.29,P=0.012)。
- 过度治疗者LTL较最佳治疗者缩短(-0.07,P=0.002)。
- 泼尼松龙治疗者LTL较氢化可的松治疗者缩短(-0.34,P<0.001)。
核心结论
- 经典型CAH患儿LTL较非经典型短,过度氢化可的松治疗或长效糖皮质激素治疗者LTL更短。
- 这些发现可能归因于长期暴露于超生理浓度的糖皮质激素,提示LTL或可作为监测糖皮质激素治疗的生物标志物。
研究设计与样本
- 前瞻性观察性队列研究,在4个学术儿童内分泌门诊开展,纳入76例基因确诊的CAH患儿,两次随访间隔平均4.1±0.7个月。
- 每次访视采用定量实时PCR测定LTL,并进行详细临床与内分泌评估,将患儿分类为治疗不足、最佳治疗或过度治疗。
- 采用线性混合模型分析临床因素对LTL的影响,校正年龄、性别和BMI-z。
主要发现
- 76例患者中31例(41%)为女孩,63例(83%)为经典型CAH,67例(88%)接受氢化可的松,8例(11%)接受泼尼松龙。
- 首次访视中位年龄12.0岁(IQR,6.3-15.1),中位BMI-z为0.51(IQR,-0.12至1.43)。
- 经典型较非经典型CAH患者LTL缩短(-0.29,P=0.012)。
- 过度治疗较最佳治疗患者LTL缩短(-0.07,P=0.002)。
- 泼尼松龙较氢化可的松治疗患者LTL缩短(-0.34,P<0.001)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Exposure to chronic stress and hypercortisolism is associated with decreased leukocyte telomere length (LTL), a marker for biological aging and cardiovascular disease. Children with congenital adrenal hyperplasia (CAH) are treated with glucocorticoids. OBJECTIVE: To investigate LTL in children with CAH. METHODS: In this prospective observational cohort study, conducted at 4 academic pediatric endocrinology outpatient clinics, children with genetically confirmed CAH were assessed at 2 follow-up visits (mean 4.1 ± 0.7 months apart). At each visit, LTL was determined by quantitative real-time PCR. All subjects underwent detailed clinical and endocrinologic evaluation and were classified as undertreated, optimally treated, or overtreated, accordingly. The influence of clinical factors on LTL was investigated using linear mixed models adjusted for age, sex, and BMI-z. RESULTS: We studied 76 patients, of whom 31 (41%) were girls, 63 (83%) had classic CAH, 67 (88%) received hydrocortisone, and 8 (11%) prednisolone. Median age at first visit was 12.0 years (IQR, 6.3-15.1), and median BMI-z was 0.51 (IQR, -0.12 to 1.43). LTL was shorter in patients with classic vs nonclassic CAH (-0.29, P = 0.012), in overtreated than in optimally treated patients (-0.07, P = 0.002), and patients receiving prednisolone compared with hydrocortisone (-0.34, P < 0.001). LTL was not associated with undertreatment or daily hydrocortisone-equivalent dose (P > 0.05). CONCLUSION: LTL is shorter in patients with classic than nonclassic CAH, and in those who are overtreated with hydrocortisone or treated with long-acting glucocorticoids. These findings may be attributed to chronic exposure to supraphysiologic glucocorticoid concentrations and indicate that LTL may be used as a biomarker for monitoring glucocorticoid treatment.
引用
- Raftopoulou C, Abawi O, Sommer G, et al. Leukocyte Telomere Length in Children With Congenital Adrenal Hyperplasia. J Clin Endocrinol Metab. 2023. PMID: 36181470. doi:10.1210/clinem/dgac560
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。